10104365An AI-driven biomanufacturing platform for the sustainable production of tailored medicinesClosedCollaborative R&DInnovate UKAlgae produce a variety of compounds that are used as active ingredients and excipients in pharmaceutical and biomedical formulations, including polymers extracted from seaweed. The seaweed supply chain is fragile and often results in variable product quality. This project will develop an alternative biomanufacturing process for the production of seaweed compounds using microalgae. PhycoWorks will use its AI-driven synthetic biology platform to develop microalgae strains that produce a tailored form of the target compound, and evaluate pilot-scale cultivation of this strain in collaboration with the AIC.